Krishna Institute of Medical Sciences Limited (BOM:543308)

Accolade Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	32,183	30,351	24,982	21,977	16,508	13,299
Revenue	32,183	30,351	24,982	21,977	16,508	13,299
Revenue Growth (YoY)	24.71%	21.49%	13.68%	33.13%	24.13%	18.46%
Cost of Revenue	12,002	12,128	10,160	8,793	6,676	5,535
Gross Profit	20,181	18,223	14,822	13,184	9,832	7,764
Selling, General & Admin	-	477	495	352.46	205.01	178.24
Other Operating Expenses	12,220	9,910	7,950	6,784	4,429	3,851
Operating Expenses	14,136	12,159	9,910	8,429	5,361	4,733
Operating Income	6,045	6,064	4,912	4,755	4,471	3,031
Interest Expense	-1,050	-887	-464	-293.18	-159.21	-293.02
Interest & Investment Income	-	102	23	95.32	122.82	57.99
Earnings From Equity Investments	-	-	-3	-	95.1	-
Other Non Operating Income (Expenses)	344	134	70	29.43	23.15	-2.9
EBT Excluding Unusual Items	5,339	5,413	4,538	4,586	4,553	2,793
Gain (Loss) on Sale of Investments	-	48	41	30.01	-	-
Gain (Loss) on Sale of Assets	-	109	4	6.1	-27.17	-10.79
Other Unusual Items	108	11	12	226.72	42.41	7.52
Pretax Income	5,447	5,581	4,595	4,849	4,569	2,790
Income Tax Expense	1,401	1,433	1,236	1,191	1,131	735.36
Earnings From Continuing Operations	4,046	4,148	3,359	3,658	3,438	2,055
Minority Interest in Earnings	-281	-303	-259	-294.91	-111.1	-42.6
Net Income	3,765	3,845	3,100	3,363	3,327	2,012
Net Income to Common	3,765	3,845	3,100	3,363	3,327	2,012
Net Income Growth	19.17%	24.03%	-7.83%	1.09%	65.33%	68.83%
Shares Outstanding (Basic)	400	400	400	400	397	374
Shares Outstanding (Diluted)	400	400	400	400	397	381
Shares Change (YoY)	-0.01%	-	-	0.74%	4.32%	1.42%
EPS (Basic)	9.41	9.61	7.75	8.41	8.38	5.37
EPS (Diluted)	9.41	9.61	7.75	8.41	8.38	5.28
EPS Growth	19.20%	24.03%	-7.83%	0.35%	58.51%	66.48%
Free Cash Flow	-	-4,271	-1,261	-1,424	1,537	2,615
Free Cash Flow Per Share	-	-10.67	-3.15	-3.56	3.87	6.87
Gross Margin	62.71%	60.04%	59.33%	59.99%	59.56%	58.38%
Operating Margin	18.78%	19.98%	19.66%	21.63%	27.09%	22.79%
Profit Margin	11.70%	12.67%	12.41%	15.30%	20.15%	15.13%
Free Cash Flow Margin	-	-14.07%	-5.05%	-6.48%	9.31%	19.67%
EBITDA	7,938	7,544	6,199	5,828	5,120	3,661
EBITDA Margin	24.66%	24.86%	24.81%	26.52%	31.01%	27.52%
D&A For EBITDA	1,893	1,480	1,287	1,073	648.09	629.24
EBIT	6,045	6,064	4,912	4,755	4,471	3,031
EBIT Margin	18.78%	19.98%	19.66%	21.63%	27.09%	22.79%
Effective Tax Rate	25.72%	25.68%	26.90%	24.56%	24.75%	26.36%
Revenue as Reported	32,527	30,670	25,143	22,236	16,711	13,401
Advertising Expenses	-	329	252	197.39	111.51	91.81

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.